PAPER Lai JZ, Lin CY, Chen SJ, Cheng YM, Abe M, Lin TC, Chien FC
SEARCH RESULTS
331159 RESULTS
PAPER McClarty BM, Rodriguez G, Dong H
Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP/PS1 mice.
Brain Res. 2024 Apr 18;:148951. PubMed: 38642789PAPER Souza ID, Lanças FM, Hallak JE, Queiroz ME
Fiber-in-tube SPME-CapLC-MS/MS method to determine Aβ peptides in cerebrospinal fluid obtained from Alzheimer's patients.
J Chromatogr A. 2024 Apr 16;1723:464913. PubMed: 38642449PAPER Corbett A, Williams G, Creese B, Hampshire A, Palmer A, Brooker H, Ballard C
Impact of Short-Term Computerized Cognitive Training on Cognition in Older Adults With and Without Genetic Risk of Alzheimer's Disease: Outcomes From the START Randomized Controlled Trial.
J Am Med Dir Assoc. 2024 Apr 17; PubMed: 38642588PAPER Li KP, Cai H
An Improved HPLC Separation Method for TSPO Radioligand [11C]ER176 Clinical Production.
J Labelled Comp Radiopharm. 2024 Apr 19; PubMed: 38641899PAPER Sulatsky MI, Stepanenko OV, Stepanenko OV, Povarova OI, Kuznetsova IM, Turoverov KK, Sulatskaya AI
Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation.
J Adv Res. 2024 Apr 18; PubMed: 38642804PAPER Onal G, Yalçın-Çakmaklı G, Özçelik CE, Boussaad I, Şeker UÖ, Fernandes HJ, Demir H, Krüger R, Elibol B, Dökmeci S, Salman MM
Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis.
J Neurochem. 2024 Apr 20; PubMed: 38641924PAPER Tong B, Ba Y, Li Z, Yang C, Su K, Qi H, Zhang D, Liu X, Wu Y, Chen Y, Ling J, Zhang J, Yu P, Yin X
Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
Neurobiol Dis. 2024 Apr 18;:106505. PubMed: 38642715PAPER Guo J, You L, Zhou Y, Hu J, Li J, Yang W, Tang X, Sun Y, Gu Y, Dong Y, Chen X, Sato C, Zinman L, Rogaeva E, Wang J, Chen Y, Zhang M
Spatial enrichment and genomic analyses reveal the link of NOMO1 with amyotrophic lateral sclerosis.
Brain. 2024 Apr 20; PubMed: 38643019PAPER Jing X, Wang L, Song M, Geng H, Li W, Huo Y, Huang A, Wang X, An C
Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment.
Sci Rep. 2024 Apr 20;14(1):9072. PubMed: 38643230PAPER Rosenthal ZC, Fass DM, Payne NC, She A, Patnaik D, Hennig KM, Tesla R, Werthmann GC, Guhl C, Reis SA, Wang X, Chen Y, Placzek M, Williams NS, Hooker J, Herz J, Mazitschek R, Haggarty SJ
Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia.
Sci Rep. 2024 Apr 20;14(1):9064. PubMed: 38643236PAPER Hans S, Stanton JE, Sauer AK, Shiels K, Saha SK, Lordan R, Tsoupras A, Zabetakis I, Grabrucker AM
Polar lipids modify Alzheimer's Disease pathology by reducing astrocyte pro-inflammatory signaling through platelet-activating factor receptor (PTAFR) modulation.
Lipids Health Dis. 2024 Apr 20;23(1):113. PubMed: 38643113Suzanne Schindler on Could New Alzheimer’s Marker p-Tau212 Rival p-Tau217?
COMMENT Kac and colleagues validated an immunoassay for plasma p-Tau212 in multiple clinical and autopsy cohorts. They demonstrated that their p-Tau212 antibody does not cross-react with p-Tau217. However, the results for their plasma p-Tau212 and p-Tau217 assays
Could New Alzheimer’s Marker p-Tau212 Rival p-Tau217?
RESEARCH NEWS 2024-04-20 Research News Among plasma biomarkers for Alzheimer’s disease, p-Tau217 stands tall as having the highest diagnostic accuracy. Now, in the March 23 Nature Communications, researchers led by Przemyslaw Kac, Thomas Karikari, and Kaj Blennow at the Universit
PAPER Li X, Bai J, Guo X, Mu Y, Di Z, Zhang G, Wang B, Zhang Y, Liu X, Shi Y, Lin S, Wu L, Bai Y, Liu X
Identifying New Subtypes of Multiple System Atrophy Using Cluster Analysis.
J Parkinsons Dis. 2024 Apr 12; PubMed: 38640168Current Filters
No filters selected